The relationship between RUNX3 inactivation and its pathological features in renal cell carcinoma

Korean Journal of Urology

Volumn 50, Issue 5, 2009, Pages 432-438

  Kwon, Whi An ^a   Park, Cheol ^a   Kim, Eun Jung ^a   Ha, Yun Sok ^a   Kim, Yong June ^a   Yun, Seok Joong ^a   Lee, Sang Cheol ^a   Kim, Wun Jae ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Human RUNX3 protein; Methylation; Renal cell carcinoma

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; DNA SEQUENCE; FEMALE; GENE INACTIVATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 66649096239     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2009.50.5.432     Document Type: Article

References (30)

1. Linehan WM, Zbar B, Bates SE, Zelefsky MJ, Yang JC. Cancer of the kidney and ureter. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott; 2001;1362-1395
2. Ficarra V, Righetti R, Pilloni S, D'amico A, Maffei N, Novella G, et al. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol 2002;41:190-198
3. Pavlovich CP, Schmidt LS, Phillips JL. The genetic basis of renal cell carcinoma. Urol Clin North Am 2003;30:437-454 (Pubitemid 37059555)
4. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999;59:71-73
5. Ohtani-Fujita N, Dryja TP, Rapaport JM, Fujita T, Matsumura S, Ozasa K, et al. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet 1997;98:43-49 (Pubitemid 27400851)
6. Horikawa Y, Sugano K, Shigyo M, Yamamoto HO, Nakazono M, Fujimoto H, et al. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. J Urol 2003;169:1541-1545 (Pubitemid 36323840)
7. Kim EJ, Kim WJ. The causal relationship between RUNX3 and bladder tumor. Korean J Urol 2005;46:1192-1198 (Pubitemid 41749090)
8. Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, et al. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007;13:2046-53 (Pubitemid 46649871)
9. Lund AH, van Lohuizen M. RUNX: a trilogy of cancer genes. Cancer Cell 2002;1:213-215 (Pubitemid 41039143)
10. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-124 (Pubitemid 34327521)
11. Bae SC, Lee YH. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene 2006;366:58-66
12. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 2005;65:9347-9354 (Pubitemid 41508002)
13. Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, et al. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 2004;314:223-228
14. Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004;23:2401-2407 (Pubitemid 38496795)
15. Xiao WH, Liu WW. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004;10:376-380 (Pubitemid 38208090)
16. Green FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002;323-328
17. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663 (Pubitemid 13234762)
18. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827-1831
19. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-708 (Pubitemid 20001591)
20. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999;96:12754-12759
21. Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 2005;23:2903-2910 (Pubitemid 46224108)
22. Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 2004;112:754-759 (Pubitemid 39435259)
23. Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol 2008;180:1141-1145
24. Rini BI, Rathmell WK. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res 2007;13:741s-6 (Pubitemid 46220104)
25. Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516-2524 (Pubitemid 43854967)
26. Won YY, Joo HJ, Cho DS, Seo KS, Ahn BC, Kim KH, et al. Correlation of caveolin-1 expression on tissue microarray with prognosis in renal cell carcinoma. Korean J Urol 2006;47:607-613 (Pubitemid 44349798)
27. 2 synthase-1 in human renal cell carcinoma. Korean J Urol 2005;46:1057-1063 (Pubitemid 41671487)
28. Kwon NS, Jo MK, Lee HM. Serum levels of vascular endothelial growth factor (VEGF) as a prognostic factor in renal cell carcinoma. Korean J Urol 2007;48:1219-1223
29. Oh BS, Park SH, Park YI. Significance of thrombocytosis as a prognostic factor after radical nephrectomy in patients with renal cell carcinoma. Korean J Urol 2004;45:1095-1099
30. Kim YK, Kim SI, Kim SJ. Significance of erythrocyte sedimentation rate and C-reactive protein as predictive factors for prognosis in non-metastatic renal cell carcinoma. Korean J Urol 2006;47:1059-1064 (Pubitemid 44811180)